China’s Kuaishou lures overseas users with ‘NSFW’ AI companions


Kuaishou Technology, operator of China’s second-largest short video app, is developing a new international revenue stream with “not-safe-for-work” (NSFW) avatars, as Chinese artificial intelligence firms compete in the lucrative field of virtual companions.

Kuaishou formally launched its AI companion service, FantaSay, through its Singapore unit, Symphony Tech, last month, after a trial run that began in February. The service promises an “ultimate immersive chat experience” with a “variety of fascinating AI companions”. It has garnered as many as 500,000 downloads, according to mobile analytics firm Sensor Tower.

AI companions are systems designed to simulate humanlike interactions, offering users personalised emotional connections, often with adult-themed content. Many of the AI companions on FantaSay have sexual elements, with some characters engaging in explicit conversations, according to a review by the Post.

Several Chinese start-ups have launched AI companion apps targeting overseas users, including Shanghai-based MiniMax’s Talkie, Beijing-based PolyBuzz and Chongqing-based HiWaifu.

About one-third of the world’s 21 most popular AI companion apps originate from China, according to Beluga Global, a platform that helps Chinese internet firms expand globally.

05:38

Chinese sex doll manufacturer tries to capitalise on DeepSeek AI boom

Chinese sex doll manufacturer tries to capitalise on DeepSeek AI boom

Kuaishou holds an advantage with its in-house AI agent development platform, Keloi, which was detailed in a sales brochure circulated by its affiliate, Beijing Qingque, last month. International users showed a “strong willingness” to pay for NSFW content, according to the brochure.

  • Related Posts

    Singapore property clan puts rare Hong Kong estate up for US$38.4 million tender

    A Singapore-rooted property family has put a rare residential estate in Hong Kong’s Southern district up for tender at about HK$300 million (US$38.4 million), testing demand for trophy homes as…

    Continue reading
    China investors energise Hong Kong biotech stocks. Is foreign money missing out?

    Mainland Chinese investors can now buy shares in more than a dozen newly added Hong Kong-listed biotech and pharmaceutical companies after a reshuffle of the Stock Connect southbound trading list…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *